CDCA7L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.996600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.832970E-01
Normal-vs-Stage2
3.813600E-01
Normal-vs-Stage3
3.244600E-01
Normal-vs-Stage4
8.957800E-01
Stage1-vs-Stage2
2.768200E-01
Stage1-vs-Stage3
8.172600E-01
Stage1-vs-Stage4
7.291900E-02
Stage2-vs-Stage3
2.864000E-01
Stage2-vs-Stage4
2.094400E-01
Stage3-vs-Stage4
7.210100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.717800E-01
Normal-vs-AfricanAmerican
9.555400E-01
Normal-vs-Asian
7.444800E-01
Caucasian-vs-AfricanAmerican
1.433800E-01
Caucasian-vs-Asian
2.095600E-01
AfricanAmerican-vs-Asian
6.800000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.715400E-01
Normal-vs-Female
3.643600E-01
Male-vs-Female
5.824800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.758430E-01
Normal-vs-Age(41-60Yrs)
5.040200E-01
Normal-vs-Age(61-80Yrs)
2.315800E-01
Normal-vs-Age(81-100Yrs)
4.747000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.293840E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.825560E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.215820E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.519230E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.002000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.002200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.226400E-01
Normal-vs-Daily Drinker
1.011990E-01
Normal-vs-Weekly Drinker
7.121600E-01
Normal-vs-Occasional Drinker
3.039600E-01
Normal-vs-Social Drinker
8.231600E-01
Non Drinker-vs-Daily Drinker
1.355830E-01
Non Drinker-vs-Weekly Drinker
7.653200E-01
Non Drinker-vs-Occasional Drinker
6.517600E-01
Non Drinker-vs-Social Drinker
6.383000E-01
Daily Drinker-vs-Weekly Drinker
2.562800E-01
Daily Drinker-vs-Occasional Drinker
3.344000E-01
Daily Drinker-vs-Social Drinker
2.291200E-01
Weekly Drinker-vs-Occasional Drinker
5.720000E-01
Weekly Drinker-vs-Social Drinker
8.669000E-01
Occasional Drinker-vs-Social Drinker
4.819800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.112400E-01
Normal-vs-Grade 2
6.423600E-01
Normal-vs-Grade 3
6.778600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.079200E-01
Grade 1-vs-Grade 3
8.870500E-02
Grade 1-vs-Grade 4
6.112400E-01
Grade 2-vs-Grade 3
2.504000E-01
Grade 2-vs-Grade 4
6.423600E-01
Grade 3-vs-Grade 4
6.778600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.742050E-01
Normal-vs-NonDiabetic
3.760200E-01
Diabetic-vs-NonDiabetic
3.484800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.261600E-01
Normal-vs-NoPancreatitis
2.787600E-01
Pancreatitis-vs-NoPancreatitis
4.797600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.450600E-01
Normal-vs-N1
3.102800E-01
N0-vs-N1
9.266000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.588200E-01
Normal-vs-TP53-NonMutant
4.805400E-01
TP53-Mutant-vs-TP53-NonMutant
8.259800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
